Oligomerization-function relationship of EGFR on living cells detected by the coiled-coil labeling and FRET

Hirotaka Yamashita1, Yoshiaki Yano1, Kenichi Kawano1

  • 1Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.

Insights

Epidermal growth factor receptor (EGFR) primarily exists as monomers, but upon epidermal growth factor (EGF) binding, it rapidly forms dimers. This dimerization precedes autophosphorylation, offering insights into EGFR signaling pathways.

Area of Science:

  • Cell biology
  • Molecular biology
  • Biophysics

Background:

  • Epidermal growth factor receptor (EGFR) is a key target in cancer therapy.
  • EGFR activity is linked to its oligomeric state, but activation mechanisms remain debated.
  • Understanding EGFR oligomerization is crucial for developing targeted therapies.

Purpose of the Study:

  • To quantitatively analyze epidermal growth factor receptor (EGFR) oligomerization on living cell membranes.
  • To investigate the receptor-ligand stoichiometry required for EGFR activation.
  • To elucidate the temporal relationship between EGFR dimerization and autophosphorylation.

Main Methods:

  • Utilized Förster resonance energy transfer (FRET) measurements.
  • Employed a coiled-coil tag-probe labeling method combined with spectral imaging.
  • Analyzed EGFR oligomerization on living CHO-K1 cell membranes at physiological expression levels.

Main Results:

  • EGFR exists mainly as monomers with a small fraction of pre-dimers in the absence of ligands.
  • Upon epidermal growth factor (EGF) stimulation, ~70% of EGFRs form dimers.
  • Ligand-induced dimerization is independent of cholesterol and GM3 levels.
  • Dimer formation occurs within 20s, preceding autophosphorylation by 70s.
  • Half-maximal dimerization occurs at a lower EGF concentration (~1 nM) than autophosphorylation (~8 nM).

Conclusions:

  • EGFR activation involves ligand-induced dimerization preceding autophosphorylation.
  • A single EGF molecule binding to a dimer may initiate activation.
  • EGFR oligomerization dynamics are critical for its signaling and therapeutic targeting.